Investment Trusts

RTW Biotech Opportunities Ltd

RTW:LSE

RTW Biotech Opportunities Ltd

Actions
  • Price (USD)2.07
  • Today's Change-0.01 / -0.48%
  • Shares traded79.88k
  • 1 Year change+55.64%
  • Beta1.1982
Data delayed at least 20 minutes, as of Feb 19 2026 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

RTW Biotech Opportunities Ltd is a Guernsey-based company focused on identifying transformative assets with high growth potential across the biopharmaceutical and medical technology sectors. The Company invests in companies developing therapies and technologies that can significantly improve patients' lives. The Company seeks to achieve its investment objective by leveraging the Investment Manager's data-driven pipeline of assets to invest in life sciences companies across various therapeutic categories and product types (including genetic medicines, biologics, traditional modalities, such as small molecule pharmaceuticals and antibodies, and medical devices). It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life. The Company's portfolio is managed by RTW Investments, LP.

  • Revenue in USD (TTM)35.11m
  • Net income in USD-92.38m
  • Incorporated2019
  • Employees0.00
More ▼

Profile

Management group(s)RTW Investments, LP
AIC sectorBiotechnology & Healthcare
ISINGG00BKTRRM22
Launch date29 Oct 2019
Share typeOrdinary Share
StructureInvestment Trust
Base currencyUSD

Objective

The Company seeks to achieve positive absolute performance and superior long-term capital appreciation, with a focus on forming, building, and supporting world-class life sciences, biopharmaceutical and medical technology companies. It intends to create a diversified portfolio of investments across a range of businesses, each pursuing the development of superior pharmacological or medical therapeutic assets to enhance the quality of life and/or extend patient life.

Managed by

Naveen Yalamanchi, Roderick Wong, Woody Stileman, Oliver Kenyon

Management & contract fees

An annual management fee of 1.25% of the NAV. If the compounded NAV return exceeds 8% p.a., the manager will be entitled to a performance fee of 20%.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Nippon Active Value Fund PLC82.16m72.64m620.92m0.008.401.17--7.560.28460.28460.32192.050.1658--30.90--14.66--14.75--94.83--88.42----34.450.0097--4.43--2.03------
North American Income Trust PLC61.33m52.45m628.62m0.0013.431.10--10.250.30230.30230.36523.680.0933--42.08--7.988.148.028.2392.2591.2485.5284.40----0.079339.216,376.1125.591,089.2530.18--5.13
Chrysalis Investments Ltd183.78m162.57m636.86m0.004.320.5645--3.470.22430.22430.24971.720.1523--25.24--13.47-1.4813.49-1.5496.51-93.7988.46-102.63--32.580.075--199.72-7.12207.17-5.57----
Foresight Group Holdings Ltd219.05m52.61m640.14m411.0012.485.4110.462.920.3320.3321.380.76560.9769--5.20394,931.9023.4621.1134.1729.7593.5894.5324.0221.69----0.174782.358.9621.8825.7738.59-16.56--
North Atlntc Smlr Cmpns Invtmnt Trst PLC45.40m30.94m647.23m0.0021.380.6544--14.260.17310.17310.25555.650.0453--3.25--3.094.113.104.1372.0479.5268.1575.70----0.0016.11369.86-13.781,851.58-15.77--24.01
JPmorgan Claverhouse Investment Trst PLC78.39m72.28m662.78m0.009.311.11--8.450.9670.9671.048.100.1203--31.82--11.092.5511.462.7593.6476.9492.2172.39----0.0628154.4414.57-17.1418.35-18.33--4.07
Blackrock Throgmorton Trust PLC-53.21m-55.48m668.30m0.00--1.01-----0.4832-0.4832-0.46036.53-0.067-------6.991.46-7.151.49--63.46--59.00----0.00123.29987.95-1.47648.11-1.14--12.03
RTW Biotech Opportunities Ltd35.11m-92.38m678.86m0.00--1.17--19.34-0.2773-0.27730.10551.770.0455--0.7047---11.977.93-14.398.6045.96-181.95-263.161,135.92--0.1390.17750.0096.37151.78-58.91-2.46----
Henderson Far East Income Ltd75.99m60.88m687.53m2.00k9.921.15--9.050.25950.25950.32952.230.1321--18.9428,153.5010.583.0311.663.2492.3280.3780.1258.45----0.1085295.6216.26--14.70----1.60
Octopus Apollo VCT PLC66.60m38.35m688.95m0.0015.440.9257--10.350.030.030.05050.50020.1013--50.18--5.837.075.917.4066.2367.9257.5960.35--88.980.0093.86284.3033.165,642.5342.22--0.00
IP Group Plc94.46m-189.06m691.46m69.00--0.5943--7.32-0.1426-0.14260.07190.9760.0595--9.401,014,493.00-11.91-1.21-11.97-1.23-----200.14-11.25--0.29730.1405--1,512.25---18.69------
Utilico Emerging Markets Trust PLC83.06m66.87m694.79m0.0010.731.02--8.370.27020.27020.33182.850.1157--28.07--9.328.869.749.0988.2686.1480.5180.51----0.040235.77-108.16---128.81----3.79
JPMorgan Emerging Markets Dvdnd Incm PLC82.91m72.47m695.29m0.0010.221.18--8.390.19180.19180.21871.670.129--29.97--11.278.0711.878.4091.3988.9987.4182.27----0.0041.3376.64--111.21----1.89
SDCL Efficiency Income Trust PLC65.05m49.53m712.61m0.0014.200.5553--10.960.03430.03430.04980.87610.0495--241.00--3.772.373.802.3775.9375.0576.1469.13----0.00275.46281.6641.14224.5143.27--4.97
Henderson Smaller Companies Inv Trst PLC15.94m7.42m726.95m0.0079.160.9805--45.620.11790.11790.17299.520.0164--7.34--0.76183.120.80273.3253.6381.3446.5679.22----0.130469.99-137.99---148.20----3.57
Pollen Street Group Ltd172.66m72.81m727.12m91.0010.180.86179.504.210.880.882.0910.400.1629--6.671,487,721.006.874.547.315.11----42.1742.05--5.200.2651--14.8213.5624.189.71----
Data as of Feb 19 2026. Currency figures normalised to RTW Biotech Opportunities Ltd's reporting currency: US Dollar USD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.